Express Scripts (ESRX) PT Lowered to $67 at Jefferies
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- S&P 500 falls as AI worries hit software makers
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Cowen is a Buyer of Express Scripts (ESRX) on Weakness
April 25, 2017 1:12 PM EDTCowen analyst Charles Rhyee is incrementally positive on Express Scripts (NASDAQ: ESRX) following the earnings call and would be buyers on today's weakness. The analyst reiterated an Outperform rating and price target of $83.
Rhyee sees limited downside risk as ANTM's contribution of... More
Express Scripts (ESRX) PT Lowered to $59 at Evercore ISI
April 25, 2017 12:43 PM EDTEvercore ISI lowered its price target on Express Scripts (NASDAQ: ESRX) to $59.00 (from $68.50) while maintaining a In Line rating.
Analyst Ross Muken commented, "Given the size / scope of the questions outstanding regarding ESRXs business model, we see valuation as... More
Express Scripts (ESRX) PT Lowered to $52 at Morgan Stanley; Renewal Cycle Could Lead to Margin Pressures
April 25, 2017 9:36 AM EDTMorgan Stanley lowered its price target on Express Scripts (NASDAQ: ESRX) to $52.00 (from $71.00) while maintaining a Underweight rating, following news that Anthem intends move its PBM business from the company.
Analyst Ricky Goldwasser lowers estimates on the announcement, suggesting the competitive landscape could deteriorate,... More
